[Treatment of diabetic patients with Optisulin-Depot CR in comparison with Depot-Insulin Hoechst klar CR--therapeutic progress?].
During a cross-over-study in 12 ambulant patients the effects of Optisulin -Depot CR in comparison to Depot-Insulin Hoechst klar CR were examined. After a period with Depot-Insulin Hoechst klar CR patients got Optisulin -Depot CR in the same dose and with the same diet. A week later patients took Depot-Insulin Hoechst klar CR once again. The different blood-sugar-curves corresponded to each other, but Optisulin -Depot CR showed more initial effect. The use of Depot-Insulin Hoechst klar CR is an advantage, because, Optisulin -Depot CR is neutral and no depot-substances are contained. Therefore, less allergic reactions are expected.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006029:Glycosuria / Q000175:diagnosis; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007657:Ketone Bodies / Q000652:urine; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic
D001786:Blood Glucose; D007328:Insulin; D007657:Ketone Bodies; C018503:insulin, depot-; C030808:insulin, (B1)-des-Phe-
Die Behandlung von Diabetikern mit Optisulin -Depot CR im Vergleich zu Depot-Insulin Hoechst klar CR - ein Fortschritt in der Therapie?